Current Revenue (30d)
$0
Verified in the last 30 days
Bio-Scry
Bio-Scry — First-of-Its-Kind Mobile Genomics Platform | Complete Software & IP Acquisition Acquire a pioneering bioinformatics platform that brings whole-genome assembly and advanced molecular biology analysis directly to an iPhone — entirely on-device, without cloud computing, expensive infrastructure or specialist hardware. Bio-Scry represents a distinctive technical achievement in scientific software. To our knowledge, it is the first iPhone platform to integrate bacterial whole-genome asse
MRR
$0
Mostly one-time sales
All-time revenue
$0
Verified lifetime total
Category rank
#150
See who ranks above · Mobile Apps
Global rank
#1383
See the global chart
Verified Revenue (30d) history
First weekThe revenue career
Oct 20$0 current
Acquisition paybackOpen TrustMRR Listing
Payback for Bio-Scry
Estimate months to break even from verified monthly revenue, your assumed net margin, and optional growth.
Estimated payback
—
Enter a price and profitable monthly revenue to see payback.
- Est. monthly profit
- $0
- Revenue multiple
- —
- Profit multiple
- —
- Annualized profit
- $0
Disclaimer: This calculator is for educational underwriting only and is not investment, financial, or legal advice. Margin and growth are your assumptions; always verify figures on the listing before you buy.
Category ladder
Full category chartMobile Apps chart
Podium leaders plus who sits near Bio-Scry. Ranked by verified 30-day revenue.
Similar Startup Explorer
Startups like Bio-Scry
Browse peers by MRR or 30d revenue, growth, market, tech stack, pricing, or customer count. Check up to 2 to compare side by side.
Select up to 2 peers to compare with Bio-Scry
Select peers firstThis week's story
Bio-Scry just landed on ChartMRR at $0 Revenue (30d). The first weekly move unlocks after the next snapshot.